JOIN US: SNO Annual 2024 Booth

Visit Plus Therapeutics at the SNO Annual Meeting in Houston – Booth #317/319

Reminder: Plus Therapeutics will be showcasing its groundbreaking radiotherapeutic advancements at the Society for Neuro-Oncology (SNO) Annual Meeting in Houston! Be sure to stop by our booth (#317/319) to learn more about how our targeted radiotherapeutics are poised to revolutionize the treatment of central nervous system cancers.

About Plus Therapeutics

Plus Therapeutics is a clinical-stage pharmaceutical company dedicated to developing innovative therapies for difficult-to-treat cancers affecting the brain and spine. Our approach combines image-guided local beta radiation with targeted drug delivery, enabling us to offer potential improvements in clinical outcomes for patients with recurrent glioblastoma (GBM), leptomeningeal metastases (LM), and other central nervous system cancers.

What We Are Presenting at SNO:

• Innovative Targeted Radiotherapies: Our pipeline focuses on developing precision treatments for glioblastoma (GBM) and leptomeningeal metastases (LM).
• Advances in Treatment: Learn how our therapies aim to improve radiotherapy and drug delivery to offer more effective, personalized treatment options for patients with metastatic brain cancer.
• Research and Development: We are committed to advancing oncology research through clinical trials and diagnostics that offer new hope for patients with rare brain cancers.

Why Visit Our Booth at SNO:

• Meet the Experts: Engage with our team of researchers and clinicians who are leading the charge in developing innovative cancer therapeutics.
• Discover Our Pipeline: Get detailed information about our ongoing clinical programs for recurrent GBM, leptomeningeal metastases, and other central nervous system cancers.
• Learn More: Gain insights into how radiotherapy and targeted drug delivery are transforming treatment options for patients with metastatic brain cancers.

Learn More About Plus Therapeutics and Our Clinical Programs
Visit our website to explore our pipeline of targeted radiotherapeutics and find out how we are working to change the landscape of brain cancer treatment: Plus Therapeutics Website

#BrainMets #BrainCancer #Glioblastoma #LeptomeningealMetastasis #GBM #CNSCancer #Radiotherapy #Therapeutics #CancerResearch #Oncology #MetastaticCancer #RadiationTherapy #RareDisease #CentralNervousSystemCancer #TargetedTherapy #ClinicalTrials #PSTV